Jeena Sikho Lifecare Ltd. (JSLL) fundamentals
Jeena Sikho Lifecare Ltd. is a listed company in Leisure Services, part of the Consumer Services sector, listed on the NSE as JSLL (ISIN INE0J5801029). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Jeena Sikho Lifecare Ltd. does
Jeena Sikho Lifecare Limited is an ayurvedic healthcare company. The Company is engaged in trading ayurvedic medicine and providing ayurvedic therapy. It provides a wide selection of Ayurvedic products that address every aspect of healthcare, from a healthy lifestyle to more serious conditions. Its products are manufactured under the brand, including Shuddhi, which provides ayurvedic herbs and products for the majority of diseases. Its products include Dr Shuddhi Package (Shuddhi Kit), a detox package, Shuddhi 32 Herbs Tea, Shuddhi Addiction Free Kit, Shuddhi BP Package, Shuddhi Diabetes Care Package, and Shuddhi Divya Sanjeevani Anti-Viral, which boosts immunity and fight against infections and germs. It also sells items under various brands, such as CAN-TAME, Ca-Nor, and Origine Naturespired, which sells wellness and beauty products. The company also offers yoga classes and various health check-up camps. It provides a range of treatments for different medical issues.
Valuation and market data
| Last close | ₹511.85 |
|---|---|
| Market capitalisation | ₹1,272 crore |
| Enterprise value | ₹1,252 crore |
| P/E (TTM) | 0.00 |
| Price to book | 4.66 |
| Price to sales (TTM) | 1.46 |
| Book value per share | ₹109.83 |
| Dividend yield | 21.49% |
| Sector | Consumer Services |
| Industry | Leisure Services |
| Listed since | Mon Aug 11 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹810 crore | ₹298 crore | ₹222 crore | 0.00 |
| Mar 2025 | ₹475 crore | ₹122 crore | ₹91 crore | 36.50 |
| Mar 2024 | ₹331 crore | ₹94 crore | ₹69 crore | 27.84 |
| Mar 2023 | ₹206 crore | ₹45 crore | ₹34 crore | 13.69 |
| Mar 2022 | ₹148 crore | ₹15 crore | ₹11 crore | 11.15 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 63.6% |
|---|---|
| Foreign institutions (FII) | 4.8% |
| Mutual funds | 0.1% |
| Other domestic institutions | 0.3% |
| Retail and others | 31.2% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.